Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Tobramycin 0.3%/fluorometholone 0.1% ophthalmic suspension |
Is a |
Product containing fluorometholone and tobramycin (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Tobramycin 0.3%/fluorometholone 0.1% ophthalmic suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Tobramycin (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Tobramycin 0.3%/fluorometholone 0.1% ophthalmic suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Adrenal hormone agent |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Tobramycin 0.3%/fluorometholone 0.1% ophthalmic suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Fluorometholone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Tobramycin 0.3%/fluorometholone 0.1% ophthalmic suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Corticosterone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Tobramycin 0.3%/fluorometholone 0.1% ophthalmic suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Glucocorticoid hormone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Tobramycin 0.3%/fluorometholone 0.1% ophthalmic suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bactericide |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Tobramycin 0.3%/fluorometholone 0.1% ophthalmic suspension |
Has manufactured dose form |
Ocular dose form (dose form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Tobramycin 0.3%/fluorometholone 0.1% ophthalmic suspension |
Is a |
Product containing fluorometholone in ocular dose form (medicinal product form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Tobramycin 0.3%/fluorometholone 0.1% ophthalmic suspension |
Is a |
Product containing tobramycin in ophthalmic dosage form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Tobramycin 0.3%/fluorometholone 0.1% ophthalmic suspension |
Has manufactured dose form |
Eye suspension |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Tobramycin 0.3%/fluorometholone 0.1% ophthalmic suspension |
Is a |
TEMPORARY parent for CDs that are not updated |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|